» 1. Aderans just initiated a real phase II trial in the U.S., with at
» least 100 cohorts. That is a serious investment for something that’s
» “dead”. Follica seems to be on to something as well.
The Aderans hairloss trial ads in the Washington, DC “Express” free paper were gone for about 2 weeks, but I noticed on Friday they started back up again.
Since the ads had been running every day for a while, it surprises me that they’d need to recruit more people. How many people do they need, anyway? Are they rejecting a lot of prospective trialists for different reasons?
One of the criteria listed is that you can’t have been using any kind of medication for hairloss for a while before the trials.
If I could take time off from work, I’d volunteer because I really am curious about whether this will work or not.
I’m not overly optimistic, but this does seem to be a well-organized trial, well funded, and they appear to be very serious about carrying it through.
Also, Aderans’ use of “scaffolds” (whatever that means) might be a way of getting around the previous failures by others.
It seems to be a way of keeping all the cells in one place, so they can coalesce into a follicle, instead of injecting them in and having them scatter randomly underneath the skin.